Kunlun Capital

Kunlun Capital is an investment firm specializing in tech-driven, innovative business models. The firm focuses on companies that leverage technology, products, and data to drive their business models. Kunlun Capital typically invests in Seed and Series B rounds, supporting early to mid-stage companies with significant growth potential.

Notable portfolio companies include Inmagene Biopharmaceuticals, which has raised $21 million, and Timely Technology, which has raised $100 million. Kunlun Capital is known for its strategic support and deep industry expertise, helping portfolio companies scale effectively. The firm's investment philosophy centers on identifying and nurturing leading companies within specific sub-sectors of technology innovation.